enGene Holdings Inc. (ENGN) is a biotech to keep an eye on with respect to the middle part of this year. That's because it is gearing up to report interim results from its open-label phase 1/2 LEGEND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback